BioCentury
ARTICLE | Clinical News

Cel-Sci to begin Phase II trial

August 21, 2000 7:00 AM UTC

CVM said it received approval to begin an additional Phase II dose optimization trial with its Multikine cytokine mixture in the Czech Republic and Poland in 20 patients with previously untreated prim...